Improving Patient Access to Stroke Therapy Study
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Identification of regional pre-hospital, hospital, and community barriers to stroke therapy
研究概览
简要总结
Limited access is a major hurdle in the treatment of AIS; many hospitals, especially rural hospitals, do not have the infrastructure or medical support to effectively treat AIS patients.5 Failure to recognize the signs and symptoms of stroke by the patient and/or emergency medical services (EMS) is another barrier to the timely treatment of AIS. Several studies, including the Paul Coverdell National Acute Stroke Registry (PCNASR), have reported low rates of adherence to stroke care guidelines, suggesting that many AIS patients do not receive proper treatment according to established guidelines. Thus, there remains an increasing need to assess and address the barriers that prevent patient access to proper AIS treatment.
Annually, approximately 20,000 patients are discharged from Wisconsin hospitals with the diagnosis of stroke and an estimated 4,000 patients die from stroke each year in WI. To date, there have been no statewide studies initiated in Wisconsin to assess the regional barriers to the treatment of AIS patients with thrombolytic or endovascular therapy, and many hospitals do not routinely collect and analyze AIS patient data.
The goal of the Improving Patient Access to Stroke Therapy (IMPACT) pilot study is to engage community hospitals statewide to identify the regional barriers to AIS therapy in WI.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age > 18 years
- •Clinical diagnosis of acute ischemic stroke or transient ischemic attack (TIA)
- •ICD-9-CM code indicative of stroke or TIA
排除标准
- •Clinical diagnosis of intracerebral hemorrhage or subarachnoid hemorrhage
- •Stroke or TIA occurred while patient was hospitalized
研究组 & 干预措施
Acute ischemic stroke or TIA
Patients presenting with acute ischemic stroke or transient ischemic attack and underwent treatment using Activase and/or endovascular therapy.
干预措施: Activase (Drug)
Acute ischemic stroke or TIA
Patients presenting with acute ischemic stroke or transient ischemic attack and underwent treatment using Activase and/or endovascular therapy.
干预措施: Endovascular therapy (Device)
结局指标
主要结局
Identification of regional pre-hospital, hospital, and community barriers to stroke therapy
时间窗: At end of study (12 months)
次要结局
- Total number of stroke patients eligible to receive Activase® versus patients eligible but did not receive Activase®(At end of study (12 months))
- Use of endovascular therapy in patients who received Activase® versus patients who did not receive Activase®(At end of study (12 months))
- Total number of stroke patients treated with acute stroke therapy(At end of study (12 months))